Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,018 across all filing types
Latest filing 2021-04-09 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
20210409 - Verwerving en vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled 'Verwerving en vervreemding van eigen aandelen' (Acquisition and disposal of own shares) and details the number of UCB shares repurchased between April 2 and April 8, 2021, including transaction dates, quantities, and prices. This directly corresponds to the definition of a company reporting transactions in its own shares. The filing type code 'POS' (Transaction in Own Shares) is the most appropriate classification. The document is short and appears to be a regulatory announcement, but the content is specific enough to warrant the dedicated 'POS' code over the general 'RPA' or 'RNS'.
2021-04-09 Dutch
210407 Transparency Declaration UCB SA (ENG).pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a 'Transparency notification' from UCB SA/NV, explicitly stating that it is filed pursuant to laws regarding the 'disclosure of large shareholdings' and details the crossing of the 3% threshold on April 1, 2021. This content directly relates to changes in significant share ownership levels by an entity, which matches the definition for Major Shareholding Notification (MRQ). Although it is a regulatory filing, MRQ is the most specific category available for this type of disclosure.
2021-04-07 English
210407 Déclaration de transparence UCB SA (FR).pdf
Major Shareholding Notification Classification · 1% confidence The document is titled "Déclaration de transparence UCB SA" (UCB SA Transparency Declaration) and explicitly references compliance with Belgian law regarding the disclosure of significant shareholdings ("loi du 2 mai 2007 relative à la publicité des participations importantes"). It details a change in the percentage of voting rights held by UCB SA, crossing the 3% threshold downwards, effective April 1, 2021. This type of filing, which reports changes in insider or significant ownership stakes, directly corresponds to the definition of Director's Dealing (DIRS) or, more broadly, Major Shareholding Notification (MRQ) if the reporting entity is not a director but a major shareholder reporting a change. Since the document reports a change in significant share ownership (crossing the 3% threshold), the most appropriate classification among the provided options is Major Shareholding Notification (MRQ). It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS), as it is highly specific to share ownership changes.
2021-04-07 French
210407 Transparantieverklaring UCB NV (NED).pdf
Major Shareholding Notification Classification · 1% confidence The document is a 'Transparantieverklaring' (Transparency Declaration) from UCB NV, dated April 7, 2021, concerning a change in significant shareholdings. It explicitly states that the notification is made based on Article 14 of the law of May 2, 2007, regarding the disclosure of major shareholdings, and that the voting rights held by UCB NV fell below the 3% threshold on April 1, 2021. This type of filing, which reports changes in ownership or voting rights that cross specific statutory thresholds, directly corresponds to the definition of a Major Shareholding Notification (MRQ). It is not an earnings release (ER), an annual report (10-K), or a director's dealing (DIRS), but a specific regulatory disclosure about share ownership.
2021-04-07 Dutch
20210402 - Acquisitions and Disposals of own shares.pdf
Transaction in Own Shares Classification · 1% confidence The document explicitly details the 'Acquisitions of own shares' and 'Disposal of own shares' conducted by UCB SA/NV under its Share Repurchase Program and in relation to Long Term Incentive Plans (LTI). This activity directly corresponds to the definition of a company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The document is a detailed disclosure, not just an announcement of a report, so RPA/RNS is not the primary classification.
2021-04-02 English
20210402 - Rachat et Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 1% confidence The document is titled "Rachat d'actions propres et aliénation d'actions propres" (Share repurchase and disposal of own shares). It details transactions where UCB SA repurchased its own shares on Euronext Brussels and alienated shares following the exercise of options by personnel (related to long-term incentive plans). This activity directly corresponds to the definition of a company reporting on transactions involving its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2021-04-02 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.